Is Eli Lilly and Company (LLY) a Buy, Sell, or Hold?
NYSE : LLY
Eli Lilly and Company — Institutional Ownership
$1196.04 USD
$10.17 (0.86%)
- Volume
- 1.59M
- Average Volume
- 3.19M
- Market Capitalization
- $1.13T
- P/E Ratio
- 42.41
- Dividend Yield
- 0.54%
- Price Target
- $1300.00
- Year High
- $1249.45
- Year Low
- $623.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.22
- Current Ratio
- $1.50
Institutional Ownership Summary
Institutional Ownership %
12.56%
Investors Holding
1579
change: -2907 | last: 4486
Increased Positions
864
change: -1291 | last: 2155
Reduced Positions
486
change: -1223 | last: 1709
New Positions
131
change: -101 | last: 232
Sold Positions
2926
change: 2601 | last: 325
Total Calls
900
Total Puts
26323
Put-Call Ratio
29.25
change: 2775.0937 | last: 1.4968
Total Invested
134.53B
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-24 | ELI LILLY & Co | 8.41M | 7.90% |
| 2026-04-20 | LILLY ENDOWMENT, INC. | 91.9M | 9.70% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-01-23 | LILLY ENDOWMENT, INC. | 92.19M | 9.80% |
| 2026-01-15 | Eli Lilly and Company | 6.34M | 11.90% |
| 2025-10-30 | The Vanguard Group | 80.95M | 8.55% |
| 2025-10-30 | LILLY ENDOWMENT, INC. | 95.49M | 10.10% |
| 2025-10-03 | ELI LILLY & Co | - | 0.00% |
| 2025-04-16 | LILLY ENDOWMENT INC | 96.02M | 10.10% |
| 2025-02-07 | THE PNC FINANCIAL SERVICES GROUP, INC. | 51.15M | 5.39% |
| 2025-01-27 | LILLY ENDOWMENT INC | 96.89M | 10.20% |
| 2023-07-07 | ELI LILLY AND COMPANY | 1.01M | 40.30% |
| 2023-07-07 | SHENANDOAH ACQUISITION CORPORATION | 797.72K | 31.90% |
| 2022-10-27 | KEARNY ACQUISITION CORPORATION | 9.64M | 25.50% |
| 2022-10-27 | ELI LILLY AND COMPANY | 9.64M | 25.50% |
| 2022-02-11 | 22-1146430 | 51.89M | 5.42% |
| 2022-02-11 | 42-1604685 | 16360.0 | 0.01% |
| 2022-02-11 | 51-0326854 | 51.89M | 5.42% |
| 2022-02-11 | Inc. 25-1435979 | 51.89M | 5.42% |
| 2022-02-11 | 81-0581990 | 28522.0 | 0.01% |
| 2022-02-10 | Eli Lilly and Company | 339.19K | 0.70% |
| 2022-02-10 | Eli Lilly and Company | 3.15M | 3.50% |
| 2022-02-10 | Eli Lilly S.A. | 2.55M | 5.80% |
| 2022-02-10 | Lilly Ventures Fund I LLC | 1.53M | 3.10% |
| 2022-02-10 | Eli Lilly and Company | 2.32M | 4.90% |
| 2022-02-10 | Eli Lilly and Company | 1.59M | 3.50% |
| 2022-02-10 | Lilly Ventures Fund I LLC | 1.59M | 3.50% |
| 2022-02-10 | Eli Lilly and Company | 2.55M | 5.80% |
| 2022-02-10 | Eli Lilly and Company | 1.53M | 3.10% |
| 2022-02-10 | Lilly Ventures Fund I LLC | 339.19K | 0.70% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 69.26M | 7.24% |
| 2022-02-08 | (1) BlackRock, Inc. | 63.88M | 6.70% |
| 2022-01-27 | LILLY ENDOWMENT INC | 107.46M | 11.23% |
| 2021-12-13 | OR | 4M | 9.70% |
| 2021-09-10 | 35-0470950 | 3.99M | 5.60% |
| 2021-02-12 | Eli Lilly and Company | 2.74M | 8.80% |
| 2021-02-12 | Eli Lilly and Company | 3.62M | 5.00% |
| 2021-02-12 | Eli Lilly and Company | 2.32M | 6.20% |
| 2021-02-12 | Inc. 25-1435979 | 52.01M | 5.44% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 68.66M | 7.18% |
| 2021-01-21 | LILLY ENDOWMENT INC | 111.13M | 11.62% |
| 2021-01-08 | Eli Lilly and Company | 3.76M | 7.17% |
| 2020-12-22 | TYTO ACQUISITION CORPORATION | 18.86M | 53.30% |
| 2020-12-22 | ELI LILLY AND COMPANY | 18.86M | 53.30% |
| 2020-02-14 | 22-1146430 | 52.13M | 5.43% |
| 2020-02-14 | Inc. 25-1435979 | 52.13M | 5.43% |
| 2020-02-14 | 42-1604685 | 13151.0 | 0.01% |
| 2020-02-14 | 27-0640560 | 634.57K | 0.07% |
| 2020-02-14 | 81-0581990 | 24550.0 | 0.01% |
| 2020-02-14 | 51-0326854 | 52.13M | 5.43% |
| 2020-01-10 | ELI LILLY AND COMPANY | 7.06M | 12.90% |
| 2020-01-10 | BALD EAGLE ACQUISITION CORPORATION | 7.06M | 12.90% |
| 2019-02-14 | Eli Lilly and Company | 293.29M | 80.20% |
| 2018-04-10 | PRIMECAP Management Company 95-3868081 | 54.55M | 4.99% |
| 2018-02-08 | Wellington Group Holdings LLP | 56.66M | 5.15% |
| 2018-02-08 | Wellington Investment Advisors Holdings LLP | 56.66M | 5.15% |
| 2018-02-08 | Wellington Management Group LLP | 56.66M | 5.15% |
| 2018-01-17 | LILLY ENDOWMENT INC | 123.08M | 11.20% |
| 2017-11-22 | Eli Lilly and Company | 2.3M | 17.50% |
| 2017-02-09 | Wellington Group Holdings LLP | 56.81M | 5.15% |
| 2017-02-09 | Wellington Investment Advisors Holdings LLP | 56.81M | 5.15% |
| 2017-02-09 | Wellington Management Group LLP | 56.81M | 5.15% |
| 2015-02-09 | The Vanguard Group | 628.5K | 5.27% |
| 2014-03-07 | PRIMECAP Management Company 95-3868081 | 56.39M | 5.00% |
| 2014-02-14 | 04-2683227 | 63.57M | 5.64% |
| 2011-02-04 | (1) BlackRock, Inc. | 60.66M | 5.26% |
| 2010-09-13 | ELI LILLY AND COMPANY | 6.3M | 11.16% |
| 2008-12-29 | Eli Lilly and Company | 3.15M | 11.90% |
| 2008-10-16 | Eli Lilly and Company | 11.67M | 13.20% |
| 2006-02-14 | 04-2683227 | 67M | 5.89% |
| 2006-02-06 | 35-0470950 | 2.5M | 3.50% |
| 2005-02-14 | persons ( | 4.17M | 7.30% |
| 2000-02-11 | Edward C. Johnson 3d | 87.25M | 8.00% |
| 2000-02-11 | FMR Corp. | 87.25M | 8.00% |
| 2000-02-11 | Abigail P. Johnson | 87.25M | 8.00% |
| 1999-01-21 | Federal I.D. No. 35-0868122 | 173.51M | 15.81% |
| 1998-02-04 | Federal I.D. No. 35-0868122 | 179.19M | 16.14% |
| 1997-01-27 | Federal I.D. No. 35-0868122 | 91.99M | 16.64% |
| 1996-01-24 | Federal I.D. No. 35-0868122 | 93.69M | 17.01% |
| 1995-02-09 | Federal I.D. No. 35-0868122 | 47.72M | 16.30% |
LLY Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1074.68 | 898M | $965.06B | $7.16B | $42.5B | $1T |
| 2024-12-31 | $772.00 | 900.6M | $695.27B | $3.27B | $33.64B | $725.64B |
| 2023-12-31 | $582.92 | 899.38M | $524.27B | $2.82B | $25.23B | $546.67B |
| 2022-12-31 | $365.84 | 950.18M | $347.61B | $2.07B | $16.24B | $361.79B |
| 2021-12-31 | $276.22 | 953.65M | $263.42B | $3.82B | $16.88B | $276.48B |
| 2020-12-31 | $168.84 | 956.59M | $161.51B | $3.66B | $16.6B | $174.45B |
| 2019-12-31 | $131.43 | 957.53M | $125.85B | $2.34B | $15.8B | $139.31B |
| 2018-12-31 | $115.72 | 1.03B | $118.93B | $7.32B | $10.3B | $121.91B |
| 2017-12-31 | $84.46 | 1.05B | $88.85B | $6.54B | $13.65B | $95.96B |
| 2016-12-31 | $73.55 | 1.1B | $80.97B | $4.58B | $10.31B | $86.69B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $919.77 | 894.5M | $822.73B | $5.14B | $43.37B | $860.97B |
| 2025-12-31 | $1074.68 | 898M | $965.06B | $7.16B | $42.5B | $1T |
| 2025-09-30 | $763.00 | 896.9M | $684.33B | $9.79B | $42.51B | $717.05B |
| 2025-06-30 | $779.53 | 897.9M | $699.94B | $3.38B | $39.9B | $736.47B |
| 2025-03-31 | $825.91 | 897.99M | $741.66B | $3.09B | $38.52B | $777.08B |
| 2024-12-31 | $772.00 | 897.54M | $692.9B | $3.27B | $33.64B | $723.28B |
| 2024-09-30 | $885.94 | 901M | $798.23B | $3.37B | $31.12B | $825.98B |
| 2024-06-30 | $914.37 | 900.9M | $823.76B | $3.22B | $28.89B | $849.42B |
| 2024-03-31 | $760.55 | 900.8M | $685.1B | $2.46B | $26.21B | $708.85B |
| 2023-12-31 | $582.92 | 899.38M | $524.27B | $2.82B | $25.23B | $546.67B |
| 2023-09-30 | $537.13 | 949.3M | $509.9B | $2.38B | $20.17B | $527.69B |
| 2023-06-30 | $468.98 | 949.29M | $445.2B | $2.69B | $18.82B | $461.32B |